Sofinnova Investments, Inc.
Position in SUPN — Supernus Pharmaceuticals, Inc.
CIK 1631134
Menlo Park, CA
Position in SUPN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$49,328,232
+$21,839,411 QoQ
Shares Held
954,309
+72.5% QoQ
Ownership
1.64%
of shares outstanding
% of Portfolio
2.47%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
7 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in SUPN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Sofinnova Investments, Inc. holds $184,364,892 across 3 Drug Manufacturers - Specialty & Generic names. SUPN ranks #2 (26.8% of the industry book) .
All Filings in SUPN
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $49,328,232 | 954,309 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $27,488,821 | 553,095 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $18,019,984 | 377,066 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $25,192,454 | 799,253 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $17,052,204 | 520,678 | Shares | Sole | 2025-05-15 | |
| 2020-09-30 | $6,883,346 | 330,295 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $11,360,313 | 478,329 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||